Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Lijian Pharmaceutical is a prominent Chinese pharmaceutical enterprise focused on the development and production of high-quality anti-infective medications. Established in 2001 and headquartered in Shenzhen's Baolong Industrial Park, the company has built a strong reputation as a specialist in cephalosporin antibiotics, including cefixime and cefdinir. Their operations are supported by large-scale, GMP-compliant manufacturing facilities capable of producing sterile powders, tablets, and capsules. While antibiotics remain their core strength, the company is diversifying its portfolio into chronic disease management, including cardiovascular and gastrointestinal treatments. Shenzhen Lijian serves a broad network of hospitals and pharmacies across China and is increasingly active in international export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Lijian Pharmaceutical.